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conjoint analysis (CA) and adaptive conjoint analysis (ACA) studies systematically quantify preferences for treatment alternatives, and measure the trade-offs people make between the characteristics of each alternative. They are grounded in Lancaster's theory of demand [1] , which assumes demand for goods and services, including health services, can be related to demand for individual characteristics of the goods or services. Further theoretical details [2] are provided in the Supplementary data, Technical Appendix A. 3 . Systematic reviews of the application of DCE, CA or ACA literature in healthcare from 1990 to 2012 [3, 4] reported rapid growth in the application of such techniques from an average of just over 3 per year between 1990 and 2000 to 48 per year between 2009 and 2012. The aims of this study were to review the nephrology DCE, CA and ACA literature published since 1990; to highlight the key trade-offs patients, clinicians and other groups make in this context; and to undertake a detailed systematic outline of study methodology.
M A T E R I A L S A N D M E T H O D S
Using keywords including (Nephrology OR Kidney OR Renal) AND (Discrete Choice OR Conjoint Analysis) in Medline, Embase, PsychINFO and Econlit from 1 January 1990 to 31 December 2015, we identified studies that used DCE, CA or ACA methodology, applied to any research question relating to nephrology. Primary studies were included in the systematic review if they contained empirical (statistical or econometric) analyses; study protocols, conference abstracts, reviews and opinions pieces were excluded. We followed criteria used in two previous reviews for study designs of this type [3, 4] , and further details are within the Supplementary data Appendices.
DCE and CA survey studies involve a comparison between two or three alternatives. The characteristics (known as attributes) of these alternatives are identical, but levels of characteristics change. Figure 1 provides an example of a DCE scenario, and Table 1 displays all of the attribute levels. With both DCE and CA formats, the range of choices faced is predetermined before choices are made. In contrast, ACA methods use similar choices, but are 'adaptive' because scenarios are generated by an adaptive computer program taking into account previous responses. These approaches (DCE, CA and ACA) have an advantage over other ranking or rating techniques such as Likert scales because they FIGURE 1: Example of a choice set (scenario) in a DCE of nephrologists' preferences for dialysis recommendation in elderly ESKD patients used in the reviewed DCE analysis cited in the reference list by Foote et al. [5] . The attribute levels were allowed to vary across choice sets as set out in table here. CAD, coronary artery disease; CVD, cerebrovascular disease; PVD, peripheral vascular disease. 
M e a s u r i n g t r a d e -o f f s i n n e p h r o l o g y
facilitate a relative 'quantitative' valuation of different characteristics as opposed to trying to value or rank the alternative as a 'whole'.
R E S U L T S
We identified 14 eligible studies from Europe, Australia, New Zealand, North America and Asia, which reported preference information for a wide range of stakeholder groups including patients, clinicians/healthcare professionals, caregivers, donors, relatives of deceased donors and the general community. Studies elicited preferences for medical interventions in kidney transplantation, health policies for organ donation and allocation, dialysis modalities and end-of-life care. Methodological criteria for each study are listed in Supplementary Tables S1-S15. We provide information about the country of analysis, number of respondents and category/categories of primary choice studies (Table 2) , as reported in previous systematic reviews of DCE, CA and ACA literature in healthcare.
Transplantation studies
A CA in the USA among 175 patients [6] investigated the acceptability of receiving a kidney from a donor at increased risk of blood-borne viral infection (DIRVI). The analysis contained three attributes relating to HIV infection risk, donor age and transplant waiting time. Findings suggested that longer waiting time (P < 0.01), lower donor age (P < 0.01), lower donor HIV risk, participant being on dialysis (P < 0.01) and older participant age (P ¼ 0.04) significantly affected preferences. Overall, 42 respondents (24%) would not accept a DIRVI kidney in any scenario; 103 (59%) would accept a DIRVI kidney in some scenarios; and 31 (18%) would accept a DIRVI kidney in all scenarios. Patients were more likely to accept DIRVI kidneys when the waiting time was longer (P < 0.01), the donor was younger (P < 0.01) and HIV risk was lower (P < 0.01). Patients on dialysis (P < 0.01) and older patients (P < 0.01) would be more likely to accept DIRVI kidneys.
Another DCE in the UK assessed preferences of 908 patients for six kidney transplant allocation criteria [7] . Findings were presented in terms of a marginal rate of substitution (MRS), i.e. a trade-off relative to waiting an additional year for a kidney transplant. Results suggested that among patients who were not from an ethnic minority group, all attributes were significant. Findings suggested a pronounced preference for prioritizing patients with moderate and not severe diseases affecting life expectancy (MRS ¼ 15.93), but paradoxically no preference for 'no diseases versus moderate diseases' affecting life expectancy. Other significant attributes included a 1% improvement in kidney survival (MRS ¼ 1.54); having an extra-dependent adult or child (MRS ¼ 1.35); a 1-year reduction in recipient age (MRS ¼ 0.16); having no disease other than kidney disease affecting quality of life (QOL) (MRS ¼ À2.48); and having moderate rather than severe diseases affecting QOL (MRS ¼ 4.08), as was transplant waiting time (MRS ¼ 1). Those who were not from ethnic minorities would prioritize transplants to patients with a better tissue match to the donor, whereas non-white ethnic minorities would not.
In a later analysis [8] , the same DCE was applied to 908 patients, 41 carers, 113 healthcare professionals and 48 live donors/relatives of deceased donors. Similarly, findings suggested a pronounced preference for prioritizing patients with moderate, not severe, diseases affecting life expectancy (MRS ¼ 15.32). A 1% improvement in kidney survival (MRS ¼ 1.41), having an extra dependent adult or child (MRS ¼ 1.43), a 1-year reduction in recipient age (MRS ¼ 0.16), having no diseases other than kidney disease affecting QOL (MRS ¼ À2.73), and having moderate rather than severe diseases affecting QOL (MRS ¼ 4.18) were also valued relative to a 1-year transplant wait. Healthcare professionals valued prioritizing patients with better tissue matches lower than patients, but prioritized younger recipients and those with dependents higher. They prioritized those with none versus moderate diseases affecting life expectancy, whereas patients did not, and they prioritized those with moderate rather than severe diseases more than patients. Assessment of preferences for live donors or relatives of deceased donors, and carers, was limited by small sample sizes.
A DCE assessed community preferences for the allocation of donor organs for transplantation (including kidneys and other organs) in Australia [9] using a sample of 2051 community respondents. This study had 15 attributes. Findings suggested most of the variables for transplant allocation criteria were significant at the 0.001 level, with the exception of having cancer previously, which was significant at the 1% level (P ¼ 0.01), and recipient sex and having diabetes, which were non-significant A second DCE analysis [10] investigated the preferences of 2005 Australian community respondents for organ donation policy. The impact of eight policy attributes was assessed. The analysis suggested that the type of donation consent system and availability of family priority for transplants in the future did not influence community preferences. Results were presented in terms of odds ratios (OR), whereby an OR >1 for an attribute 
Dialysis studies
A CA in the USA examined the willingness of 126 patients to switch dialysis modality from conventional to more frequent dialysis [12] . The authors established the impact of four attributes including life expectancy, QOL, the annual number of hospitalizations and transport time. All four attributes were significantly associated with a willingness to switch to daily haemodialysis in the hypothesized direction. Findings showed that 44% of respondents receiving conventional haemodialysis three times per week would not switch to daily six times per week haemodialysis regardless of the health benefits. Of the 56% who said they might switch to this regimen, the majority would only switch for substantive health benefits.
A second dialysis DCE investigated public preferences among 206 respondents for the location of dialysis facilities for residents of Greenland [13] . This involved three attributes including recruitment of nephrologists, location of patient accommodation and increase in taxation required for dialysis. All the variables relating to these three attributes were significant at the 1% level, and standard deviations were significant for all random parameter logit variables (indicating statistically significant preference heterogeneity-see Supplementary data, Appendix A.2 for details). A key finding was that hypothetical alternatives involving treatment in Greenland (versus treatment in Denmark) were chosen in nearly two-thirds of cases, implying a 'slight tendency' to favour treatment in Greenland despite increased taxation. Respondents were willing to pay 30 euros more in increased taxes per person per year to see a permanent nephrologist rather than a non-permanent (visiting) nephrologist. The provision of accommodation required to undertake dialysis in apartments was valued at 70 euros, and in hotels at 88 euros of increased taxation per person per year. The statistically significant model constant implied an overall preference in favour of dialysis in Greenland (valued at 63 euros).
A DCE in Australia assessed preferences for dialysis modality among 105 pre-dialysis patients and 73 caregivers [15] . Informed by preliminary research [19, 20] , three treatment alternatives for home dialysis, in-centre dialysis and non-dialytic conservative care were created. The alternatives were described by seven attributes including average survival time, number of visits per week to hospital for dialysis, ability to travel or 'go away' on short trips, hours of dialysis per treatment, time of day the dialysis can be undertaken, provision of a transport service to attend dialysis or doctors' appointments and whether there was flexibility to change dialysis and times. Findings reported home-based dialysis was chosen 65% of the time and in-centre dialysis 35% of the time. Comparing dialysis versus conservative care, 90% of respondents chose a dialysis option and 10% chose a non-dialysis (conservative care) option. In the main analysis for patients, two variables for home-based dialysis [life expectancy (OR 1.68), travel restrictions (OR 0.37)] were significant with another eight variables that were non-significant. Similarly, one attribute for in-centre haemodialysis [longer hours (OR 2.02)] was significant. Among caregivers, home dialysis was chosen 72% of the time, in-centre dialysis 25% of the time and conservative care 3% of the time. Moreover, three out of nine variables relating to home dialysis compared with conservative care [life expectancy (OR 1.82), dialysis at night (OR 0.03) and travel restrictions with home dialysis (OR 0.43)] were significant. Similarly, among caregivers when comparing incentre haemodialysis with conservative care, 2 out of 11 variables [dialysis at night time (OR 0.03) and hours with in-centre dialysis (OR 2.67)] were significant. All significant variables were in the expected direction.
A second analysis from the same research teams [16] elicited preferences among 105 respondents for dialysis versus conservative non-dialytic care in Australia. Findings suggested patients preferred dialysis to conservative care if dialysis increased average life expectancy (OR 1.84; 95% CI 1.57-2.15), if they could dialyse during the day or evening rather than during the day only (OR 8.95; 95% CI 4.46-17.97) and if subsidized transport was available (OR 1.55; 95% CI 1.24-1.95). Patients were less likely to choose dialysis over conservative care if more hospital visits were required (OR 0.70; 95% CI 0.56-0.88) and with more restrictions on travel (OR 0.47; 95% CI 0.36-0.61). Patients would forgo 7 months life expectancy to reduce the number of visits to the hospital, and 15 months to increase their ability to travel.
Another DCE [5] looked at the preferences of 159 Australian nephrologists for dialysis in elderly patients with end-stage kidney disease (ESKD). The DCE included 10 attributes. Findings indicated all patient characteristics (except sex) significantly affected the likelihood of nephrologists recommending dialysis. Nephrologists were more likely to recommend dialysis for patients with preserved cognition (OR 68.3; 95% CI 33.4-140.0), lower comorbidity (OR 2.1; 95% CI 1.1-4.1), increased life expectancy (OR 2.8; 95% CI 2.1-3.7), high current QOL (OR 2.8; 95% CI 2.0-3.8), and positive patient and family dialysis inclination (OR 27.5; 95% CI 16.2-46.8 and OR 2.0; 95% CI 1.3-3.3, respectively). Nephrologists over 65 years of age were more likely to recommend dialysis than younger nephrologists. Overall, nephrologists would forgo 12 months of patient survival to avoid substantial QOL decreases associated with dialysis.
An ACA [18] investigated preferences among 305 US nephrologists for blood transfusion in chronic dialysis patients. The analysis incorporated 10 attributes. Findings presented in terms of relative importance of attributes suggested that haemoglobin level (g/dL) accounted for 29% of decision-making, followed by functional status (16%), cardiovascular disease (12%), clinical scenario (9%), erythropoiesis-stimulating agent status (9%), age (7%), haemoglobin stability over time (6%), kidney transplant eligibility (5%), iron indices (4%) and evidence of occult blood in stool: Fecal Occult Blood Test or Fecal Immunochemical Test being positive (3%).
Combined dialysis, end-of-life and transplantation
One Canadian DCE [11] assessed the preferences of 169 patients, 29 caregivers and 150 healthcare professionals. Dialysisrelated attributes included 'Who provides comprehensive day to day care for patients on dialysis?' and 'How decisions to stop dialysis should be made?' Transplantation attributes included 'How deceased donor kidneys should be allocated for transplantation?' and 'How should live kidneys for transplantation be obtained?' Other attributes related to 'end-of-life' issues included 'When should end-of-life care discussions commence?' and 'How much information on prognosis and end-oflife care issues should be routinely provided?' All the attributes were significant, with the exception of some levels for the attribute about who provides comprehensive day-to-day care on dialysis. Regression coefficients suggested that for all respondents early 'end-of-life care' discussions (0.72) were preferred to late (0.00); detailed information on prognosis and end-of-life care was preferred to limited information (0.56 versus 0.00); whereas medical and personal decisions (0.34) as opposed to personal decisions only (0.00) was preferred for decisions about stopping dialysis.
In relation to how deceased donor kidneys should be allocated, the 'best match' approach (0.81) was preferred to 'first come first served' (0.00). With respect to how live kidneys for transplantation should be obtained, receiving an organ from an unknown donor (À0.43), via a paired kidney exchange (À0.80) or buying a kidney (À1.93) were less preferable than receiving a kidney from a family member or close friend (0.00). For the attribute of providing day-to-day dialysis care, the family physician (À0.51) was less preferable than 'family physician and group of kidney specialists' (0.25), while the 'advanced nurse practitioner and group of kidney specialists' was nonsignificant.
Renal cancer studies
A DCE assessed 120 patients, 52 family members and 272 healthcare professionals' preferences for targeted renal cell carcinoma therapy in South Korea [17] . The analysis involved six attributes. All the attributes were significant at the 1% level for patients and health professionals. Additional months of progression-free survival were positively valued at 7-31% in terms of relative importance, additional months of bone marrow suppression was negatively valued at 18-36%, the increased likelihood of hand-foot skin reaction was negatively valued at 12-23%, increased likelihood of gastrointestinal perforation was valued between 4 and 13%, increased risk of bleeding was valued between 11-14% and administration by injection versus orally was valued at 13-22% in terms of relative importance of attributes according to the stakeholder group.
A second DCE assessed benefit-risk preferences for targeted agents in the treatment of renal cell carcinoma in 138 US patients [14] . The respondents faced questions relating to hypothetical renal cell carcinoma profiles. The profiles were defined by attributes including efficacy [progression-free survival (PFS), when overall survival was constant], tolerability effects (fatigue/ tiredness, diarrhoea, hand-foot syndrome, mouth sores) and serious adverse events (liver failure, blood clot). Findings suggested PFS was the most important attribute for patients. The remaining attributes were ranked in decreasing order of importance: fatigue/tiredness, diarrhoea, liver failure, hand-foot syndrome, blood clot and mouth sores. A key finding was that to increase PFS by 11 months, patients would accept a maximum blood clot risk of 3.1% (95% CI 1.5-5.3) or liver failure risk of 2.0% (95% CI 1.0-3.3).
D I S C U S S I O N
DCE and CA studies provide several advantages above traditional surveys. First, they provide a quantitative estimate of the 'relative' importance of one attribute of a treatment or programme compared with another, rather than a rating (e.g. Likert scale) or a ranking (simple ordering of characteristics from most important to least important). The estimate of relative importance enables the researcher to calculate trade-offs, i.e. what amount of one attribute a person is prepared to give up in order to gain more of another attribute. This trade-off cannot be calculated from traditional surveys. Secondly, DCE and CA studies allow the estimation of preferences for options that do not yet exist-for example, a policy to reimburse a kidney donor for their personal time given to be screened for donation, attend the required medical visits and recover from their donor nephrectomy operation. This is possible because DCEs and CAs use hypothetical scenarios containing plausible and realistic attributes. Thirdly, DCEs and CAs enable market forecasting of new treatments that can help in health service planning. For example, planning integrated renal-palliative care medical services based on the proportion of people with ESKD who might choose conservative kidney management if the alternative were offered to them.
The difficulties of DCEs and CAs compared with other surveys may include the minimum level of cognitive ability that is required to comprehend the choice question posed. The cognitive burden is considered greater than a simple rating or ranking task. In nephrology, this can be an issue if one seeks to elicit preferences from people with advanced CKD. A second difficulty compared with traditional surveys is the level of statistical or econometric expertise needed in the design and analysis of the DCE or CA surveys. At a minimum, the analyst needs to have good quantitative data skills, and familiarity with regression analysis and writing code in statistical software such as Nlogit. However, the challenges are not insurmountable, as many universities run specific training courses in DCE design and analysis, and economists/health economists have applied these techniques in different areas for close to two decades.
The published literature in nephrology provides important insights about the preferences of key stakeholder groups for treatment of kidney disease, highlighting several major implications for policy. In kidney transplantation, the current allocation criterion of 'first come first served' is broadly consistent with preference studies, in particular the value placed on 'equity' criteria for prioritizing those who have waited a long time; however, other factors not currently considered may be equally important. These include the donor status of the patient or family, the number of previous transplants, and whether the recipient has child or adult dependents. This would indicate that the current allocation policy in many countries needs to change. In dialysis, two separate DCE studies found a preference among patients for longer rather than shorter treatment time (i.e. hours or number of days per week) when resulting health benefits could be delivered. This indicates that the current minimum standards in international dialysis guidelines for fluid and solute clearance may not be aligned with patient preferences, and provision of other modalities such as home dialysis that enable increased hours, should be offered.
Looking to the future, several choice studies in nephrology are planned, including patient preferences for kidney transplant monitoring by video-conferencing [21] , preferences for outcomes after kidney transplantation [22] , and patient and family preferences for home versus facility-based dialysis in New Zealand [23] .
C O N C L U S I O N S
This review has evaluated the content and methodology of choice studies in nephrology. These study designs are increasingly used to obtain information about key preferences in kidney transplantation and dialysis. In contrast to other methods, they provide quantitative information about respondents' trade-offs between conflicting objectives, and can establish how policy-relevant preferences vary among stakeholder groups.
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